Cirrhosis Clinical Trial
— FrAILTOfficial title:
Functional Assessment in Liver Transplantation
NCT number | NCT03870568 |
Other study ID # | 015-243 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | October 6, 2015 |
Est. completion date | December 2025 |
In order to ensure the equity of the liver allocation process, it is important to create objective, scientifically validated markers of frailty in patients with end-stage liver disease that accurately predict patient outcomes. Many measures have been developed to assess this clinical state in elderly patients, but none have been applied to patients with cirrhosis, a population at increased risk for accelerated functional decline. This protocol is designed to learn more about the effects of functional status (also known as "frailty") in liver transplant patients and patient outcomes both before and after liver transplant.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | December 2025 |
Est. primary completion date | December 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adults (=18 years old) - Listed for liver transplantation, or are "listable" - i.e, have undergone formal evaluation and been approved for listing if/when patients achieve high enough priority - Are seen in the outpatient clinic setting Exclusion Criteria: - Have severe hepatic encephalopathy at enrollment (defined by the time to complete the Numbers Connection Test (NCT) > 120 seconds, which is the first test that the participants complete upon enrollment). |
Country | Name | City | State |
---|---|---|---|
United States | Baylor University Medical Center | Dallas | Texas |
Lead Sponsor | Collaborator |
---|---|
Baylor Research Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in measurements of fried frailty before and after liver transplantation. | The changes in frailty score pre and post transplant will be evaluated. | 5 years | |
Other | Change in measurements of liver frailty before and after liver transplantation. | The changes in frailty score pre and post transplant will be evaluated. | 5 years | |
Primary | Fried Frailty Index measurements in 300 patients with end-stage liver disease awaiting liver transplantation | Fried Frailty is calculated by combining into one score measurements of:
Exhaustion: number of days patient felt exhaustion in the past 7 days Physical activity: has the subject performed any weight bearing activity in the past month? (Possible answers: yes or no). Grip strength test using dynamometer: Three measurements reported in kg. Walking speed in a 13-foot (4 meters) walk: Three measurements reported in seconds Unintentional Weight Loss: report if patient has lost 10 lbs or more in the last year. Minnesota Leisure Time Physical Activity Questionnaire (MNLTPA) calculated as a value of 1 for males with MNLTPA score less than 383 kcal/week and for females with a score less than 270 kcal/week. Range of score is 0 to 5 with 0 being not frail and 5 being most frail |
5 years | |
Primary | Liver Frailty Index measurements in 300 patients with end-stage liver disease awaiting liver transplantation | The following measurements are used individually to assess liver frailty index:
Chair stands: The patient stands up from a sitting position without using his/her arms. The time (in seconds) the patient requires to complete the task is reported. Balance testing: patients must stand up in side by side, semi tandem and tandem positions for 10 seconds each. If the subject can't hold position for 10 seconds, the number of seconds that the subject kept in position is reported. Scoring range is 1.0 to 7.0 with 1.0 to 3.0 being "robust" and 4.5 to 7.0 being "frail" |
5 years | |
Primary | Numbers Connection test measurements in 300 patients with end-stage liver disease | Patient connects numbers that are scattered at random on a piece of paper. Reported as time (in seconds) taken to connect the numbers. | 5 years | |
Primary | Work status | Possible answers: working, retired, on disability, other. | 5 years | |
Primary | Hospitalizations | Possible answers: yes or no. If yes, report #of nights and reason. | 5 years | |
Primary | Activities of daily living (ADLs) | Six questions about daily activities Scoring: A response of yes to any of the questions receives a value of 1. the ADL score is measured as the sum of the values of the 6 questions. A score of 0 correlates with "most dependent" and a score of 6 is "most independent." | At 1 year post transplantation | |
Primary | Instrumental Activities of Daily Living (IADLs) | Eight questions about daily activities:
Scoring: each question can be answered with a score of 0 or 1. The final iADL score is the sum of all values. The range of the score is 0 to 8 with 0 being most dependent and 8 being "most independent.' |
At 1 year post transplantation | |
Primary | 36 Item Short Form Survey Instrument (SF-36) | Patient will complete a 36 question questionnaire about quality of life at 1 year post transplantation. | At 1 year post transplantation | |
Secondary | Correlation between frailty and outcomes both before and after liver transplantation. | The association between the subject's frailty score and their pre and post transplant outcomes will be assessed. | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01884415 -
Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
|
Phase 3 | |
Recruiting |
NCT05014594 -
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
|
Phase 2 | |
Not yet recruiting |
NCT03631147 -
The Effect of Rifaximin on Portal Vein Thrombosis
|
N/A | |
Completed |
NCT04939350 -
Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021
|
||
Completed |
NCT02528760 -
To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis
|
N/A | |
Recruiting |
NCT05484206 -
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
|
Phase 1 | |
Not yet recruiting |
NCT05538546 -
Baveno VI Criteria in Dynamic Monitoring of High-risk Varices in Compensated Cirrhotic Patients
|
||
Not yet recruiting |
NCT04053231 -
Hepatocarcinoma Recurrence on the Liver Study - Part2
|
||
Recruiting |
NCT02983968 -
Use of the French Healthcare Insurance Database
|
||
Completed |
NCT02705534 -
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1
|
Phase 3 | |
Completed |
NCT02596880 -
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics
|
Phase 3 | |
Completed |
NCT02247414 -
Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
|
Phase 4 | |
Withdrawn |
NCT01956864 -
Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer
|
Phase 1 | |
Completed |
NCT02016196 -
Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS
|
Phase 3 | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Completed |
NCT01447537 -
Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis
|
N/A | |
Completed |
NCT02113631 -
Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir
|
N/A | |
Active, not recruiting |
NCT01205074 -
¹³C-Methacetin Breath Test (MBT) Methodology Study
|
Phase 2/Phase 3 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT01231828 -
Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies.
|
N/A |